GHRP-2 (5mg) protocols focus on this synthetic growth hormone-releasing peptide (GHRP) studied for its ability to stimulate natural growth hormone (GH) release via ghrelin receptor activation. It may support muscle growth, fat metabolism, recovery, and improved sleep quality. This guide outlines a subcutaneous administration approach optimized for the 5 mg vial format.
Concise summary of the subcutaneous regimen.
Suggested approach for the 5 mg vial format.
GHRP-2 is a synthetic peptide that binds to the ghrelin receptor (growth hormone secretagogue receptor, GHS-R) in the pituitary and hypothalamus. This stimulates pulsatile release of growth hormone independent of growth hormone-releasing hormone (GHRH).
By increasing GH levels, it may subsequently elevate IGF-1 (Insulin-like Growth Factor-1), which plays a role in muscle growth, tissue repair, and metabolism. GHRP-2 is also known for its potential effect on appetite stimulation due to its interaction with ghrelin pathways.
Observations based on preclinical and early-stage research.
Potential Benefits:
Possible Side Effects: